First Bank & Trust »

Bridgebio Pharma shares owned by First Bank & Trust

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by First Bank & Trust from 13F filings

Historical chart of First Bank & Trust investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by First Bank & Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by First Bank & Trust

Quarter filed Position value Share count Share price at filing
2024-03-31 $248k 8.0k 30.92

More positions owned by First Bank & Trust

Van Ttl Stk Mkt Equities (VTI)
Vanguard FTSE Dev Equities (VEA)
iShares Core Equities (AGG)
Vanguard FTSE Emg Equities (VWO)
Vanguard Index Fd Et Equities (VOO)
Microsoft Corp Equities (MSFT)
iShares Core S&P Scp Equities (IJR)
Big Sioux Financial Equities
iShares Tr Core S&P Equities (IJH)
Daktronics Equities (DAKT)
Vanguard S&P 500 Val Equities (VOOV)
Vanguard Sp 600 Val Equities (VIOV)
Nvidia Corporation Equities (NVDA)
Total Sa- Equities (TTE)
S&P 500 Catholic Equities (CATH)

View all positions for First Bank & Trust

Top funds holding Bridgebio Pharma

Kohlberg Kravis Roberts & Co
Viking Global Investors
Vanguard Group
Aisling Capital Management
Laurion Capital Management
Cormorant Asset Management
Goldman Sachs Group
Lord, Abbett & Co
Frazier Life Sciences Management
Alliancebernstein
Perceptive Advisors
Citigroup
Wellington Management Company
Hillhouse Capital Advisors
Norges Bank Investment Management

View all funds holding Bridgebio Pharma